首页
登录
职称英语
Doctors are to begin a trial of a drug treatment that could double the time
Doctors are to begin a trial of a drug treatment that could double the time
游客
2023-07-08
48
管理
问题
Doctors are to begin a trial of a drug treatment that could double the time transplanted organs survive in the body. The 20-minute procedure effectively coats donor organs in a protective shield that stops them being rejected by the patient’s immune system.
The treatment is expected to prolong the time that organs remain healthy in patients’ bodies and also increase their shelf-life(保存期限), so they can be stored for longer or transported further before being used. If the treatment works, it could ease the burden on organ transplant services, which face an increasing gap between the supply and demand for donor organs.
People who receive transplants must take drugs to suppress their immune systems, but the body still reacts enough to cause transplants to fail sooner than they should. A healthy transplanted kidney lasts on average only 10 years, around one third of the time it should last. Organs such as hearts and livers fail even sooner. The consequence is that patients who have had one donor organ often need another.
The new treatment, developed by researchers at King’s College London, is based on the defense mechanism healthy organs use to shield themselves from the immune system. Studies suggest the procedure could extend the life of an implanted kidney by around seven years. The scientists believe the treatment will also extend the shelf-life of donor organs, increasing the time they survive outside the body from no more than 24 hours to several days. This could reduce wastage and double the number of organs that work properly once they are transplanted, doctors said. In early tests, only a fifth of organs worked properly after being stored on ice for 16 hours, compared with 50% of those treated with mirococept(药物:米罗西普).
A recent pilot study of the treatment on 16 patients found it was safe to use. Patients who receive donated organs treated with mirococept will still need to take drugs to suppress their immune systems, but doctors said an aim of their research was to see if the use of current drugs, which can increase a patient’s risk of cancer, can be reduced. [br] What can we learn from the recent pilot study of the treatment?
选项
A、The new drug treatment can be used widely someday.
B、The treatment will destroy the immune system.
C、The current drug can increase a patient’s risk of cancer.
D、The result of the pilot study doesn’t satisfy the researchers.
答案
A
解析
推理判断题。文章最后一段提到,该研究发现这一方法是安全的。由此可以推断,将来这一处理方法可以被广泛应用,故A)为正确答案。
转载请注明原文地址:https://tihaiku.com/zcyy/2818832.html
相关试题推荐
Thedoctorsaysthat______(这项新的疗法有助于防止艾滋病的发展).thenewtreatmentwillhelppreven
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
Yearsago,doctorsoftensaidthatpainwasanormalpartoflife.Inpartic
随机试题
[originaltext]InJune,mybandperformedatapartyataLowerEastSidebo
下列物质在体内可直接还原生成脱氧腺苷酸的是()A.腺苷 B.cAMP C
患者男性.32岁,慢性肾衰竭尿毒症期.反复出现心力衰竭,下列哪项是病因:A.钠
各级别轿车历年销售份额(%) 相对于2001年,10年的销售份额增长率最大
共用题干 第一篇TheMakingofaSuccessStoryIK
定额水平( ),员工经过很大努力仍达不到,就会减少员工的收入,挫伤员工的积极性
2017年11月25日,甲(2003年11月26日出生)在公
单位活期存款账户中的一般存款账户不得办理()。 A.转账结算B.现金支取
甲公司2016年12月20日购入一项不需安装的固定资产。入账价值为
某产品目标总成本为1000元,各功能区现实成本及功能重要性系数见下表,则应降
最新回复
(
0
)